(Circulation. 1998;98:2049-2054.)
© 1998 American Heart Association, Inc.
Basic Science Reports |
Ovarian Ablation Alone Promotes Aortic Intimal Hyperplasia and Accumulation of Fibroblast Growth Factor
From the Departments of Surgery (C.H.S., S.M.J., T.A.W., A.H.H.) and Medicine (L.D.H.), University of Colorado Health Sciences Center, Denver, and the College of Veterinary Medicine, Colorado State University (J.S.G., A.S.T.), Fort Collins.
Correspondence to Craig H. Selzman, MD, Department of Surgery, UCHSC, Box C-320, 4200 E Ninth Ave, Denver, CO 80262. E-mail craig.selzman{at}uchsc.edu
Background—Estrogen-mediated cardiovascular protection is incompletely explained by its beneficial lipid-modifying effects. Previous studies interrogating direct vascular effects of estrogens have used models of either diet- or injury-induced atherosclerosis. The purpose of this study was to determine the influence of ovarian ablation alone on vascular remodeling. We hypothesized that estrogens are atheroprotective, independent of their influence on lipid metabolism, by directly influencing the production and effects of a prototypical atherogenic mediator, basic fibroblast growth factor (bFGF).
Methods and Results—Twenty-five female sheep were randomized to sham operation, ovariectomy, or ovariectomy plus 17ß-estradiol replacement. Serum cholesterol and triglyceride levels were serially measured for 1 year and were similar among groups and in the normal range (30 to 60 mg/dL). At 6, 9, and 12 months, ovariectomy resulted in aortoiliac intimal hyperplasia compared with sham (P<0.01) and hormone replacement (P<0.01) groups. The neointima of ovariectomized animals was characterized immunohistochemically by increased vascular smooth muscle cells (VSMCs). Levels of bFGF protein were determined in adjacent aortic segments. Ovariectomized sheep had 2-fold more FGF than sham or ovariectomized sheep that received hormone replacement. In vitro, estradiol inhibited the mitogenic effect of bFGF on human aortic VSMCs.
Conclusions—Without dietary manipulation, ovarian ablation alone induces aortic intimal hyperplasia in the ewe. Estradiol abrogates this response independently of its effects on serum lipids. Hormone replacement decreases the accumulation of the atherogenic peptide bFGF in vivo and inhibits the mitogenic response of VSMCs to bFGF in vitro. These results suggest that estrogens may provide atheroprotection both by modulating local production and by attenuating the influence of bFGF on VSMC growth.
Key Words: hormones • muscle, smooth • growth substances • atherosclerosis
This article has been cited by other articles:
 |
|
 |
|
  C. K. Sen, S. Khanna, and S. Roy Perceived hyperoxia: Oxygen-induced remodeling of the reoxygenated heart Cardiovasc Res, July 15, 2006; 71(2): 280 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ling, A. Dai, R. J. Dilley, M. Jones, E. Simpson, P. A. Komesaroff, and K. Sudhir Endogenous Estrogen Deficiency Reduces Proliferation and Enhances Apoptosis-Related Death in Vascular Smooth Muscle Cells: Insights From the Aromatase-Knockout Mouse Circulation, February 3, 2004; 109(4): 537 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Zimmerman, L. L. Reznikov, A. C. Sorensen, and C. H. Selzman Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2003; 284(5): R1213 - R1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Zimmerman, C. H. Selzman, L. L. Reznikov, S. A. Miller, C. D. Raeburn, J. Emmick, X. Meng, and A. H. Harken Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R505 - R512. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Zimmerman, C. H. Selzman, L. L. Reznikov, C. D. Raeburn, K. Barsness, R. C. McIntyre Jr., C. R. Hamiel, and A. H. Harken Interleukin-11 attenuates human vascular smooth muscle cell proliferation Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H175 - H180. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Selzman, A. S. Turner, J. S. Gaynor, S. A. Miller, E. Monnet, and A. H. Harken Inhibition of Intimal Hyperplasia Using the Selective Estrogen Receptor Modulator Raloxifene Arch Surg, March 1, 2002; 137(3): 333 - 336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Selzman, S. A. Miller, and A. H. Harken Therapeutic implications of inflammation in atherosclerotic cardiovascular disease Ann. Thorac. Surg., June 1, 2001; 71(6): 2066 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D Horwitz and E. A Rosenthal The authors' reply Vascular Medicine, May 1, 2000; 5(2): 128 - 128. [PDF]
|
|
|
|
 |
|
 C. Dong and P. J. Goldschmidt-Clermont Bone Sialoprotein and the Paradox of Angiogenesis Versus Atherosclerosis Circ. Res., April 28, 2000; 86(8): 827 - 828. [Full Text] [PDF]
|
|
|
|
|
|
Y. K. Hodges, L. Tung, X.-D. Yan, J. D. Graham, K. B. Horwitz, and L. D. Horwitz Estrogen Receptors {alpha} and {beta} : Prevalence of Estrogen Receptor {beta} mRNA in Human Vascular Smooth Muscle and Transcriptional Effects Circulation, April 18, 2000; 101(15): 1792 - 1798. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Hayward, R. P. Kelly, and P. Collins The roles of gender, the menopause and hormone replacement on cardiovascular function Cardiovasc Res, April 1, 2000; 46(1): 28 - 49. [Full Text] [PDF]
|
|
|
|
|
|
I. Moussa and J. W. Moses Angiogenesis for Treatment of Ischemic Heart Disease: Should We Worry About Progression of Atherosclerosis? Circulation, November 30, 1999; 100 (22): e109 - e109. [Full Text] [PDF]
|
|
|
|
 |
|
 V M Miller Gender and vascular reactivity Lupus, June 1, 1999; 8(5): 409 - 415. [Abstract] [PDF]
|
|
|
|
|
|
C. H. Selzman, B. D. Shames, R. C. McIntyre Jr, A. Banerjee, and A. H. Harken The NF{{kappa}}B inhibitory peptide, I{{kappa}}B{{alpha}}, prevents human vascular smooth muscle proliferation Ann. Thorac. Surg., May 1, 1999; 67(5): 1227 - 1231. [Abstract] [Full Text] [PDF]
|
|